The effect of addition of calcipotriol ointment (50 pg/g) to acitretin therapy in psoriasis;Der Effekt einer Zugabe von Calcipotriol-Salbe (50 M9/9) zu einer Acitretin-Behandlung der Psoriasis

H+G Zeitschrift fur Hautkrankheiten

Volumn 73, Issue 1, 1998, Pages 47-52

  Van De Kerkhof, P C M ^a,l   Cambazard, F ^b   Hutchinson, P E ^c   Haneke, E ^d   Wong, E ^e   Souteyrand, P ^f   Damstra, R J ^g   Combemale, P ^h   Neumann, M H A M ⁱ   Chalmers, R J G ^j   Olsen, L ^k   Revuz, J ^e  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Hôpital St Etienne Nord   (United Kingdom)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

^d Ferdinand Sauerbruch Klinikum   (United Kingdom)

^e ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^f Services de Dermatologie   (United Kingdom)

^g Ziekenhuis Nij Smellighe   (United Kingdom)

^h Services de Dermatologie   (United Kingdom)

ⁱ MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^j HOPE HOSPITAL   (United Kingdom)

^k LEO PHARMA A S   (Denmark)

^l Hôpital Henri Mondor   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0006855066     PISSN: 03010481     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Saurat, J. H.: Side effects of systemic retinoids and their clinical management. J Am Acad Dermatol 1992; 27:23-28.
2. Goilnick, H., Bauer, R., Brindley, C. et al: Acitretin versus etretinate in psoriasis. J Am Acad Dermatol 1988; 19:458-469.
3. Kragballe, K., Jansen, C. T., Geiger, J. M. et al: A double blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Acta Derm Venereol (Stockh) 1989; 69: 35-40.
4. Saurat, J. H., Geiger, J. M., Amblard, P. et al: Randomized double blind multicentre study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis. Dermatologica 1988; 177:218-224.
5. Orianos, C. E., Steigleder, G. K., Pullman, H. et al: Oral retinoid and UVB radiation. Acta Derm Venereol (Stockh) 1979; 59:241-244.
6. Binderup, L, Bramm, E.: Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol 1988; 37:889895.
7. Kragballe, K.: WC903, a non-calciotropic vitamin DS analogue stimulates differentiation and inhibits proliferation of cultured human keratinocytes. J Invest Dermatol 1988; 91:383.
8. Kragbaile, K., Beck, H. I., Sogaard, H.: Improvement of psoriasis by a topical vitamin Ü3 analogue (MC903) in àdouble blind study. Br J Dermatol 1988:119: 223-230.
9. Kragballe, K.: Treatment of psoriasis by the topical application of the novel vitamin 03 analogue (MC903) in double blind study. Arch Dermato/1989; 125:1647-1652.
10. Cunliffe, W. J., Berth-Jones, J., Claudy, A. et al: Comparative study of calcipotriol (MC903) ointment and betamethasone 17-va!erate ointment in patients with psoriasis vulgaris. J Am Acad Dermalen 992; 26: 736-743.
11. Kragbulle, K., Tore Gjertsen, B., de Hoop, D. étal: Double blind right/left comparison of calcipotriol and betamethasone valerate in the treatment of psoriasis vulgaris. Lancet 1991; 337: 193-196.
12. van de Kerkhof, P. C. M.: Dithranol treatment for psoriasis. After 75 years still going strong. Eur JDermatol 1991; 1: 79-89.
13. Grossman, R. M., Thivolet, J., Claudy, A. et al: A novel therapeutic approach to psoriasis: combination calcipotriol ointment and very low dose cyclosporin. J Am Acad Dermatol 1994; 31:68-70.
14. Frappaz, A., Thivolet, J.: Calcipotriol in combination with PUVA a randomized double blind placebo study in severe ps'oriasis. Eur J Dermatol 1993; 3:364-367.
15. Ramsay, C. A., Berth-Jones, J., Brundin, G. etal: Long-term use of topical calcipotriol in chronic plaque psoriasis. Dermatology 1994; 189:260-264.
16. Frederiksson, t., Pettersson, U.: Severe psoriasis-oral therapy with a new retinoid. Dermatotog/ca 1978; 157: 238-244.
17. Carlberg, C., Bendik, I., Wyss, A. et al: Two . nuclear signalling pathways for vitamin D. Wature 1993; 361:657-660.
18. Carlberg, C.: The vitamin D3 receptor in the context of the nuclear receptor .superfamily. The central role of retinoid X receptor. Endocrine 1996; 4:91-105.
19. Chentoufi, J., Marie, P. J.: Interactions between retinole acid and 1.25 (OH) 2Ds in mouse immortalized osteoblastic C1 cells. Am J Physiol 1994; 266:1247-1256.
20. van de Kerkhof, P. C. M.: Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms. Br J Dermatol 1995; 132:675-682.